• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Titan Pharmaceuticals Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

    12/29/23 8:51:40 AM ET
    $ASST
    $BBLG
    $BYN
    $CGA
    Computer Software: Prepackaged Software
    Technology
    Industrial Specialties
    Health Care
    Get the next $ASST alert in real time by email

    Shares of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) rose sharply in today’s pre-market trading session.

    Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split.

    Titan Pharmaceuticals shares jumped 15.2% to $0.38 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • China Green Agriculture, Inc. (NYSE:CGA) shares gained 173.2% to $5.19 in pre-market trading. On Dec. 27, China Green Agriculture entered into a stock purchase agreement with Zhibiao Pan for the acquisition of all outstanding stock of Lonestar Dream for a total consideration of $49 million.
    • FLJ Group Limited(NASDAQ:FLJ) gained 94.8% to $2.63 in pre-market trading. FLJ Group completed $180 million cash purchase of Alpha Mind Technology and terminated equity acquisition agreement entered into with Lianlian Holdings Inc.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) rose 71% to $0.33 in pre-market trading after gaining 7% on Thursday.
    • cbdMD, Inc. (NYSE:YCBD) shares rose 27.8% to $1.01 in pre-market trading after gaining 11% on Thursday.
    • CN Energy Group. Inc. (NASDAQ:CNEY) shares gained 19.7% to $0.0720 in pre-market trading after gaining around 20% on Thursday.
    • Green Giant Inc. (NASDAQ:GGE) shares rose 14% to $0.0595 in pre-market trading. Green Giant recently announced pricing of public offering.
    • Genius Group Limited (NYSE:GNS) shares gained 11.4% to $0.7686 in pre-market trading. Genius Group recently updated financial guidance for the financial year ending December 31, 2023.
    • Dunxin Financial Holdings Limited (NYSE:DXF) gained 11.3% to $0.38 in pre-market trading.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:GV) shares climbed 10.2% to $0.23 in pre-market trading.

    Losers

    • flyExclusive Inc (NYSE:FLYX) shares fell 24.1% to $5.20 in pre-market trading after dipping over 42% on Thursday.
    • Cingulate Inc. (NASDAQ:CING) shares fell 23.1% to $7.55 in pre-market trading. Cingulate shares jumped 146% on Thursday after the company announced it received guidance from the FDA regarding its clinical program for CTx-1301.
    • SenesTech, Inc. (NASDAQ:SNES) shares fell 23.1% to $1.33 in pre-market trading after jumping over 100% on Thursday. Earlier in December SenesTech announced substantial initial orders for its Evolve Soft Bait product which controls pests through a nontoxic method of fertility control. The company also announced its entry into an exclusive distribution agreement with Fruit Tree Limited, a pest control company based in Hong Kong.
    • Banyan Acquisition Corporation (NYSE:BYN) shares fell 20.8% to $10.25 in pre-market trading after jumping 42% on Thursday.
    • Nova LifeStyle, Inc. (NASDAQ:NVFY) fell 18.2% to $3.84 in pre-market trading after jumping 203% on Thursday.
    • Sidus Space, Inc. (NASDAQ:SIDU) shares fell 17.3% to $9.51 in pre-market trading. Sidus Space shares surged 163% on Thursday amid increased volatility after the company highlighted its 2023 achievements which it says have laid the groundwork for an anticipated launch in Q1 2024.
    • Ucommune International Ltd (NASDAQ:UK) shares fell 17.2% to $4.30 in pre-market trading after jumping over 71% on Thursday. Ucommune recently regained compliance with Nasdaq minimum bid price requirement.
    • Asset Entities Inc. (NASDAQ:ASST) shares fell 14.4% to $0.5315 in pre-market trading after adding around 5% on Thursday.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares fell 13.5% to $5.19 in pre-market trading after gaining 29% on Thursday. Bone Biologics' stock recently effected a 1-for-8 reverse-split on Dec. 20, and the company also announced the closing of a direct offering of 1,139,063 shares of common stock at a purchase price of $0.64 per share on Nov. 20.
    • DatChat, Inc. (NASDAQ:DATS) fell 12.4% to $2.88 in pre-market trading. On Dec. 27, 2023, Datchat filed a certificate of change in Nevada to increase its authorized common stock from 18 million to 180 million shares.

     

    Now Read This: Top 4 Utilities Stocks That Could Sink Your Portfolio In December

    Get the next $ASST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASST
    $BBLG
    $BYN
    $CGA

    CompanyDatePrice TargetRatingAnalyst
    Strive Inc.
    $ASST
    3/10/2026$12.00Buy
    B. Riley Securities
    Cingulate Inc.
    $CING
    1/10/2025$12.00Buy
    ROTH MKM
    Cingulate Inc.
    $CING
    12/22/2023Buy → Hold
    Laidlaw
    Cingulate Inc.
    $CING
    1/20/2022$8.50Buy
    Laidlaw & Co.
    Kintara Therapeutics Inc.
    $KTRA
    1/20/2022$6.00 → $3.00Buy
    HC Wainwright & Co.
    Cingulate Inc.
    $CING
    1/11/2022$9.00Buy
    Aegis Capital
    Kintara Therapeutics Inc.
    $KTRA
    9/30/2021$7.00 → $5.00Buy
    Aegis Capital
    Kintara Therapeutics Inc.
    $KTRA
    9/28/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $ASST
    $BBLG
    $BYN
    $CGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strive, Inc. Announces Financial Results

    DALLAS, March 19, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced its financial results for the fourth quarter ended December 31, 2025. Key Highlights Since Strive's Public Listing in September 2025: Accumulated a total of 13,628 bitcoin as of March 17, 2026. 5,886 bitcoin from initial PIPE proceeds and 351 exchange.5,048 bitcoin from acquisition of Semler Scientific, Inc.2,694 bitcoin from other capital markets activity, including SATA IPO and follow-on, ASST ATM, and SATA ATM. Achieved a Bitcoin Yield of 22.2% in Q4 2025 and 13.8% QTD (as of March 17, 2026) in Q1 2026.Generated a Bitcoin Gain of ₿1,305 BTC in Q4 2025 and ₿1

    3/19/26 8:00:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

    KANSAS CITY, Kan., March 18, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended December 31, 2025, and provided a corporate update. Highlights include recent U.S. and European patent developments, the closing of a $12 million private investment, and the acceptance of a New Drug Application (NDA) for its lead candidate, CTx-1301 (dexmethylphenidate HCl). Cingulate CEO Shane J. Schaffer stated, "Cingulate delivered on key inflection points throughout 2025 and this continues i

    3/18/26 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Genius Group CEO Roger Hamilton Buys 300,000 Company Shares on the Open Market

    SINGAPORE, March 17, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has received notice that its CEO and Founder, Roger Hamilton, has made a further purchase of the Company's shares at market price. Mr. Hamilton notified the Company he purchased 300,000 of the Company's shares on March 13, 2025 on the open market, at an average price of $0.37 per share. Mr. Hamilton has purchased a total of 5.5 million shares of the company for a total of US$2.9 million over a series of seven separate transactions since January 2024. Mr. Hamilton said "Insider purchases of the company

    3/17/26 8:00:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ASST
    $BBLG
    $BYN
    $CGA
    SEC Filings

    View All

    SEC Form 10-K filed by Strive Inc.

    10-K - Strive, Inc. (0001920406) (Filer)

    3/19/26 5:21:04 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Eason Technology Limited

    6-K - Eason Technology Ltd (0001499494) (Filer)

    3/19/26 4:05:07 PM ET
    $DXF
    Finance: Consumer Services
    Finance

    Strive Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Strive, Inc. (0001920406) (Filer)

    3/19/26 7:59:47 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $BBLG
    $BYN
    $CGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cole Matthew Ryan

    4 - Strive, Inc. (0001920406) (Issuer)

    3/19/26 5:50:42 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    EVP and CSO Silva Raul R. was granted 4,526 shares and covered exercise/tax liability with 1,828 shares, increasing direct ownership by 139% to 4,645 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    3/11/26 8:13:31 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASST
    $BBLG
    $BYN
    $CGA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Strive with a new price target

    B. Riley Securities initiated coverage of Strive with a rating of Buy and set a new price target of $12.00

    3/10/26 8:42:37 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    ROTH MKM initiated coverage on Cingulate with a new price target

    ROTH MKM initiated coverage of Cingulate with a rating of Buy and set a new price target of $12.00

    1/10/25 7:39:52 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate downgraded by Laidlaw

    Laidlaw downgraded Cingulate from Buy to Hold

    12/22/23 7:22:08 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASST
    $BBLG
    $BYN
    $CGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASST
    $BBLG
    $BYN
    $CGA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ASST
    $BBLG
    $BYN
    $CGA
    Financials

    Live finance-specific insights

    View All

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Strive Adds $50M of STRC to its Corporate Treasury

    Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) ("Strategy") today announced that Strive, Inc. ("Strive") has allocated $50 million, representing over one-third of its corporate treasury, to STRC (Strategy's Variable Rate Series A Perpetual Stretch Preferred Stock). "We are encouraged to see innovative institutions continue integrating STRC into their treasury strategies," said Phong Le, Chief Executive Officer of Strategy. "Prevalon Energy, Anchorage Digital, and OranjeBTC have already added STRC to their corporate treasuries, and Strive is now the latest corporation to publicly announce doing so. Adoption continues to grow as more institutions recognize the role Digital Credit can play in mode

    3/11/26 9:00:00 AM ET
    $ASST
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    Strive Announces SATA Enhancements and Purchase of Bitcoin & STRC

    DALLAS, March 11, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced the following updates: SATA dividend rate increased by 25 bps to 12.75%. Dividend declared of $1.0625 per share of SATA Stock to stockholders of record the close of business on April 1, 2026, payable on April 15, 2026Targeted SATA price range narrowed to $99-$101 from $95-$105Updated guidance to not issue SATA via ATM or follow-on offerings below $100.00Purchased 179 additional Bitcoin since last filing and now holds approximately 13,311 BTCPurchased $50 million (500,000 shares) of Strategy Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC)SATA divid

    3/11/26 8:00:00 AM ET
    $ASST
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $ASST
    $BBLG
    $BYN
    $CGA
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications